Imperial College London operations Research

By | 16th June 2017

Imperial College London operations Research

Operational Research

The view through a microscope in the field.

Working at the forefront of research

SCI have developed a Monitoring, Evaluation and Research Strategy, which includes the priority areas of operational research (OR) that the organisation will be focusing on over the next 5 years. These OR priorities have been defined by the SCI team and in-country partners in line with SCI’s overall strategic objectives and those of the wider global agenda for schistosomiasis (SCH) and soil-transmitted helminth (STH) control i.e. WHO’s Roadmap for NTD Elimination and Uniting to Combat NTDs Scorecard. The OR focuses on addressing questions which will lead to improving large scale implementation of effective schistosomiasis and STH programmes targeting control of morbidity and, in increasing areas, moving towards elimination. The three core areas where SCI has the strength, skills and platforms necessary to broaden understanding and knowledge in the field of schistosomiasis and STH are

  • Understanding programme acceptance and uptake
  • Increasing breadth of evidence for elimination of schistosomiasis and STH
  • Enhancing programme delivery of preventive chemotherapy

Imperial College London operations Research

The Operations Management theme studies the design and management of production and business processes across the manufacturing and services sectors, focusing particularly on pricing and revenue management, the interface between operations management and marketing, decision-making under uncertainty, as well as stochastic programming and robust optimisation. The research team has close ties with the Computational Optimisation Group, the Centre for Process Systems Engineering and the KPMG Centre for Advanced Business Analytics.


Summary of the project:

The Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) is supporting efforts in Mozambique to understand the benefits and costs of alternative approaches to preventive chemotherapy (PC) for urinary schistosomiasis (Schistosoma haematobium) in high prevalence (>25%) communities. In total five years of S.haematobium infection data has been collected from 81,167 individuals across 150 communities in Cabo Delgado province, Northern Mozambique, to accurately assess the benefits of different approaches to large scale administration of treatment with Praziquantel (PZQ).

Application: One of the primary objectives is to attain a quantifiable decrease in schistosome prevalence and intensity across a whole age profile as a result of treatment. These results will show SCI and other countries the most effective treatment strategy in terms of reduction in parasite reduction as well as cost-efficiency.